 |
| Research article summary (published 30 Jan 2003): |
Sertraline treatment of elderly patients with depression and cognitive impairment.
Full Abstract
BACKGROUND:
There is little information on the efficacy and side effects of antidepressant treatment in elderly patients with combined depression and cognitive impairment without dementia (DEP-MCI), and it is unclear if cognitive performance improves with antidepressant response in these patients.
METHODS:
In 39 elderly DEP-MCI patients, changes in depression and cognitive impairment were evaluated with open sertraline treatment up to 200 mg/day for 12 weeks.
RESULTS:
Of the 26 completers, 17 were responders and nine were non-responders. Diagnostic subtype of depression was unrelated to response. ANCOVA on WAIS-R digit symbol percent change scores revealed a significant effect for responder status (F = 5.59, p < 0.03), and age (F = 0.24, p < 0.64) and education (F = 1.64, p < 0.22) were not significant covariates. From pre-trial to post-trial, responders improved in WAIS-R digit symbol percent change scores (Mean -10% SD 24) while non-responders declined (Mean 14% SD 18; t = 2.60, p < 0.02). Other neuropsychological measures were unrelated to response. Percent change in HRSD scores showed significant inverse correlations with percent change in several cognitive measures.
CONCLUSIONS:
DEP-MCI patients showed moderate clinical response to sertraline treatment. When responders were compared to non-responders, cognitive improvement was limited to one measure of attention and executive function. Overall, there was little cognitive improvement with antidepressant treatment. The findings indirectly suggest that lack of improvement in cognition following treatment of depression in DEP-MCI patients may be associated with increased risk of meeting diagnostic criteria for dementia during follow-up.Copyright 2003 John Wiley & Sons, Ltd.
Learn Faster Today Improve your study skills
Author information
Author/s: Devanand, D P (DP); Pelton, Gregory H (GH); Marston, Kristin (K); Camacho, Yesenia (Y); Roose, Steven P (SP); Stern, Yaakov (Y); Sackeim, Harold A (HA);
Affiliation: Late Life Depression Clinic, Memory Disorders Center, Department of Biological Psychiatry, New York State Psychiatric Institute, 1051 Riverside Drive, Unit 26, New York, NY 10032, USA. dpd3@columbia.edu
Grants: MH 50513 (Agency:United States NIMH) ; MH 55716 (Agency:United States NIMH) ; P50 AG 08702 (Agency:United States NIA)
Journal and publication information
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal: International journal of geriatric psychiatry (Int J Geriatr Psychiatry), published in England. (Language: eng)
Reference: 2003-Feb; vol 18 (issue 2) : pp 123-30
Dates: Created 2003/02/06; Completed 2003/03/21; Revised 2007/11/14;
PMID: 12571820, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.